Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASC40 drug-drug interaction study in healthy volunteers
NCT04843449Phase 1Completed
- Sponsor
- Ascletis Pharma Inc.
- Start
- Apr 2021
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial of denifanstat, sponsored by Ascletis Pharma Inc. Primary endpoints: Area under the plasma concentration-time curve of ASC40, Maximum observed plasma concentration of ASC40 and 2 more. Started Apr 2021; status: completed.
02
Drugs
denifanstat
Beyond the preview
Go deeper on NCT04843449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04843449.